Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain blood flow differs between sexes – new study explores why

NCT ID NCT04265053

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 35 times

Summary

This completed early-phase study looked at how sex and stress influence blood flow in the brain. Researchers gave 42 healthy young adults indomethacin (an anti-inflammatory drug) or a placebo to test whether a specific mechanism (COX signaling) explains differences between men and women. The goal is to gather knowledge that could lead to better, sex-specific treatments for brain blood vessel diseases.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL ARTERIAL DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Wisconsin, Madison

    Madison, Wisconsin, 53706, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Indomethacin

What this could lead to

If successful, this could point toward sex-specific therapies for cerebrovascular diseases like stroke.

What could go wrong

This is a very early, small study in healthy young adults, so findings may not apply to older or sick populations. The drug used (indomethacin) is not being tested as a treatment here.

Conditions

The condition(s) this trial relates to.

cerebral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.